← All Enliven Therapeutics, INC filings

Enliven Therapeutics, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
ELVN
Enliven Therapeutics, INC
10-K: Enliven Therapeutics Reports Promising Clinical Data and Outlines Future Development Plans in 10-K Filing
Enliven Therapeutics' 10-K filing highlights ongoing clinical trials for ELVN-001 and ELVN-002, along with plans for future development and strategic collaborations.
NASDAQ
ELVN
Enliven Therapeutics, INC
10-K: Enliven Therapeutics Outlines Capital Structure and Corporate Governance in 10-K Filing
Enliven Therapeutics' 10-K filing details its authorized capital stock, voting rights, and anti-takeover provisions, alongside updates on its clinical programs and financial status.